24HourWire
News from all angles
MedPage Today
Center
Novel HDAC Inhibitor Hits Main Goal in Unresectable Melanoma Trial
(MedPage Today) -- Progression-free survival (PFS) in unresectable melanoma improved significantly with the addition of an investigational histone deacetylase (HDAC) inhibitor to immunotherapy, a ran…